High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis

Salas, MQ; Prem, S; Remberger, M; Lam, W; Kim, DDH; Michelis, FV; Al-Shaibani, Z; Gerbitz, A; Lipton, JH; Viswabandya, A; Kumar, R; Kumar, D; Mattsson, J; Law, AD

Law, AD (corresponding author), Univ Toronto, Dept Med, Div Med Oncol & Hematol,Princess Margaret Canc Ct, Hans Messner Allogene Blood & Marrow Transplantat, Rm 6-711 OPG Bldg,700 Univ Ave, Toronto, ON M5G 1Z5, Canada.

LEUKEMIA & LYMPHOMA, 2020; 61 (13): 3198

Abstract

We explore risk factors and impacts of post-transplant EBV-Reactivation (EBV-R) and PTLD in 270 patients that underwent RIC alloHCT using ATG-PTCy and......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索